Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

Detection of simultaneous beta-herpesvirus infections in clinical syndromes due to defined cytomegalovirus infection.

Razonable RR, Rivero A, Brown RA, Hart GD, Espy MJ, van Cruijsen H, Wilson J, Groettum C, Kremers W, Smith TF, Paya CV.

Clin Transplant. 2003 Apr;17(2):114-20.

PMID:
12709076
2.

Descriptions of blood and blood disorders before the advent of laboratory studies.

Hart GD.

Br J Haematol. 2001 Dec;115(4):719-28. No abstract available.

PMID:
11843802
3.

Prophylaxis for CMV should now replace pre-emptive therapy in solid organ transplantation.

Hart GD, Paya CV.

Rev Med Virol. 2001 Mar-Apr;11(2):73-81. Review.

PMID:
11262526
4.

A cell line derived from a clinically benign phyllodes tumor: characterization and implications.

Warso MA, Mehta RR, Hart GD, Graves JM, Green A.

Anticancer Res. 1995 Mar-Apr;15(2):399-404.

PMID:
7763012
5.

Growth and metastasis of human breast carcinomas with Matrigel in athymic mice.

Mehta RR, Graves JM, Hart GD, Shilkaitis A, Das Gupta TK.

Breast Cancer Res Treat. 1993;25(1):65-71.

PMID:
8518409
6.

Human breast carcinoma cell lines: ultrastructural, genotypic, and immunocytochemical characterization.

Mehta RR, Bratescu L, Graves JM, Hart GD, Shilkaitis A, Green A, Beattie CW, Das Gupta TK.

Anticancer Res. 1992 May-Jun;12(3):683-92.

PMID:
1377894
7.

Cellular retinol binding protein and breast carcinoma.

Mehta RR, Hart GD.

Eur J Cancer. 1990;26(8):888-91.

PMID:
2145932
8.

The World Health Organization and cancer.

Hart GD.

Can Med Assoc J. 1985 Aug 15;133(4):269-71. No abstract available.

9.

Mycobacterium chelonei: report of a case of septicemia and review of the literature.

Righter J, Hart GD, Howes M.

Diagn Microbiol Infect Dis. 1983 Dec;1(4):323-9. Review.

PMID:
6365421
10.

Relapsing septicemia caused by Campylobacter fetus subsp. fetus.

Righter J, Wells WA, Hart GD, McNeely DJ.

Can Med Assoc J. 1983 Mar 15;128(6):686-9. No abstract available.

11.

Anemia in ancient times.

Hart GD.

Blood Cells. 1981;7(3):485-93. No abstract available.

PMID:
7039724
12.

Blood group testing of ancient material with particular reference to the mummy Nakht.

Hart GD, Kvas I, Soots M.

Transfusion. 1978 Jul-Aug;18(4):474-8.

PMID:
684801
13.

Dr. D.a.e. Shephard.

Hart GD.

Can Med Assoc J. 1977 Sep 17;117(6):577. No abstract available.

14.

Autopsy of an Egyptian mummy. 9. Blood group testing.

Hart GD, Kvas I, Soots ML.

Can Med Assoc J. 1977 Sep 3;117(5):476. No abstract available.

15.

Autopsy of an Egyptian mummy. 3. Gross anatomic and miscellaneous studies.

Scott JW, Horne PD, Hart GD, Savage H.

Can Med Assoc J. 1977 Sep 3;117(5):464-9. No abstract available.

16.

Lessons learned from the autopsy of an Egyptian mummy.

Hart GD, Cockburn A, Millet NB, Scott JW.

Can Med Assoc J. 1977 Sep 3;117(5):415-8. No abstract available.

17.
18.

The I.V. nurse.

Hart GD.

Hosp Adm Can. 1976 Oct;18(10):62, 64. No abstract available.

PMID:
10241845
19.

The diagnosis of disease from ancient coins.

Hart GD.

Archaeology. 1973 Apr;26:123-7. No abstract available.

PMID:
11620339
20.

Leiomyosarcoma of the stomach with 45-year survival.

Hart GD, Soots ML, Yoshida S.

Can Med Assoc J. 1972 Dec 23;107(12):1208-9 passim. No abstract available.

21.

The earliest medical use of the caduceus.

Hart GD.

Can Med Assoc J. 1972 Dec 9;107(11):1107-10. No abstract available.

22.

Leukemia on myeloma.

Quirt IC, Hart GD, Soots M.

Br Med J. 1972 Jan 22;1(5794):248. No abstract available.

23.

Treatment of Reiter's syndrome with methotrexate.

Topp JR, Fam AG, Hart GD.

Can Med Assoc J. 1971 Dec 4;105(11):1168-9 passim. No abstract available.

24.

The Habsburg jaw.

Hart GD.

Can Med Assoc J. 1971 Apr 3;104(7):601-3. No abstract available.

25.

Reaction to iron sorbitol injection.

Soots M, Hart GD.

Br Med J. 1970 Oct 3;4(5726):54. No abstract available.

26.

Significance of extreme elevation of erythrocyte sedimentation rate.

Hart GD, Soots M, Sullivan J.

Appl Ther. 1970 Aug;12(8):12-3. No abstract available.

PMID:
5469564
27.

A numismatist looks at coin lesions.

Hart GD.

Appl Ther. 1970 Feb;12(2):12-5. No abstract available.

PMID:
5434643
28.

A hematological artifact from 4th century Britain.

Hart GD.

Bull Hist Med. 1970 Jan-Feb;44(1):76-9. No abstract available.

PMID:
4909176
29.

Clinical evaluation of Rho(D) immune globulin (human) in Canada.

Bryant EC, Hart GD, Cairns D, Gamarra JA, de Veber LL, Holland CG, Hutchison JL.

Can Med Assoc J. 1969 Dec 13;101(12):82-3.

30.

An anaphylactic reaction complicating total dose infusion therapy of iron deficiency.

Hart GD, Soots M.

Appl Ther. 1969 Dec;11(12):645-6. No abstract available.

PMID:
5364340
31.

Intracavity 5-fluorouracil for control of malignant effusions.

Hart GD, Soots ML.

Appl Ther. 1968 Nov;10(11):760-2. No abstract available.

PMID:
5704294
32.

Systemic 5-fluorouracil for palliation of gastrointestinal cancer.

Hart GD, Maxwell SB, Soots ML.

Appl Ther. 1968 Oct;10(10):670-2. No abstract available.

PMID:
4177674
33.

Even the gods had goitre.

Hart GD.

Can Med Assoc J. 1967 Oct 21;97(17):1035-6. No abstract available.

34.

Widespread necrotizing arteritis in rheumatoid arthritis: report of a patient who survived.

Topp JR, Hart GD.

Can Med Assoc J. 1967 Aug 19;97(8):412-5. No abstract available.

35.

The confederation worm token.

Hart GD.

Can Med Assoc J. 1967 Jul 1;97(1):39-40. No abstract available.

36.

The influence of morphology on prognosis in acute leukemia.

Hasselback R, Curtis J, Soots M, Robertson GL, Cowan DH, Hart GD.

Can Med Assoc J. 1967 Jun 24;96(25):1610-4.

37.

Even the gods had goitre.

Hart GD.

Can Med Assoc J. 1967 May 27;96(21):1432-6. No abstract available.

38.

Cancer of the ovary.

Hart GD.

Can Med Assoc J. 1967 May 20;96(20):1384. No abstract available.

39.

Treatment of Rh hemolytic disease by passive immunization.

Hart GD.

Appl Ther. 1967 Apr;9(4):372-4. No abstract available.

PMID:
4962682
40.

English token coins and medicine.

Hart GD.

Can Med Assoc J. 1966 Dec 17;95(25):1311-7. No abstract available.

41.

Trichoepithelioma and the kings of ancient Parthia.

Hart GD.

Can Med Assoc J. 1966 Mar 12;94(11):547-9. No abstract available.

42.

Ancient coins and medicine.

Hart GD.

Can Med Assoc J. 1966 Jan 8;94(2):77-89. No abstract available.

43.

ASCLEPIUS, GOD OF MEDICINE.

HART GD.

Can Med Assoc J. 1965 Jan 30;92:232-6. No abstract available.

44.

Museum of the Toronto Academy of Medicine.

Hart GD.

Can Med Assoc J. 1964 Oct 3;91(14):769. No abstract available.

45.

ACUTE LEUKEMIA FOLLOWING PHENYLBUTAZONE THERAPY.

HART GD.

Can Med Assoc J. 1964 Aug 29;91:449-50. No abstract available.

46.

LEUKAEMIA AND PHENYLBUTAZONE.

HART GD.

Br Med J. 1964 Aug 29;2(5408):569. No abstract available.

47.

A GROWING SPECTRUM FOR THE ANTIMETABOLITES.

HART GD.

Appl Ther. 1964 Jul;6:596-8. No abstract available.

PMID:
14179437
48.

PALLIATIVE MANAGEMENT OF GASTROINTESTINAL CANCER.

HART GD.

Can Med Assoc J. 1964 May 30;90:1265-8.

49.

Idiopathic Hypoparathyroidism with Impaired Vitamin B(12) Absorption.

Hart GD.

Can Med Assoc J. 1962 Sep 29;87(13):721. No abstract available.

50.

Chemotherapy of malignant disease: a review of theory and practice.

HART GD.

Can Med Assoc J. 1962 Mar 31;86:575-83. No abstract available.

Supplemental Content

Support Center